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SLC26A4 and its murine ortholog Slc26a4 code for pendrin, an anion-exchanger that is 
expressed in the inner ear.  Patients with mutations in SLC26A4 have syndromic or non-
syndromic hearing loss that is associated with a prenatal enlargement of the membranous 
labyrinth.  The mouse model Slc26a4
Δ/Δ
 recapitulates the enlargement, develops an enlargement 
of the inner ear and fails to acquire hearing.  The vestibular labyrinth secretes fluid, accounting 
for enlargement of the membranous labyrinth.  The objective of the current study was to measure 
K
+




 mice as a first step 
toward a mechanistic understanding of fluid secretion during perinatal development.  Double-
barreled K
+
-selective electrodes were used to measure K
+
 concentrations of the utricular 
endolymph in vitro.  Potassium concentrations were ~10 mM in both genotypes at embryonic (E) 
day 16.5. The K
+
 concentrations started to rise at E17.5 in Slc26a4
Δ/+
 mice.  There was a 1-day 
delay in Slc26a4
Δ/Δ   
mice.  This delay may be the consequence of a larger fluid volume.  K
+
 




 adult mice, 






 cotransporter SLC12A2 




 mice.  In conclusion, the data 
suggest that K
+
 secretion is not the major driving force of fluid secretion in the utricle of the 
developing mouse inner ear.  
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Chapter 1 - Introduction 
Mammalian ears consist of the outer ear, the middle ear and the inner ear (Figure 1-1).  
The inner ear consists of the pinna, the external auditory canal and the tympanic membrane.  The 
pinna is made of cartilage and skin.  It collects and directs sound waves through and external 
auditory canal to the tympanic membrane and causes it to vibrate.  The middle ear and the inner 
ear are located inside the temporal bones of the skull.  The middle ear is connected to the back of 
the nose and throat through the Eustachian tube.  The middle ear is an air-filled cavity consisting 
of three ossicles known as the malleus, incus and stapes, which transmit sound.  Sound waves 
reach the tympanic membrane and induce vibration, in turn causing the movement of the three 
ossicles.  The stapes transform sound energy into mechanical energy.  The inner ear consists of 
two epithelial compartments, the cochlea and the vestibular labyrinth.  The cochlea, which looks 
like a snail, is involved with hearing.  The vestibular labyrinth, consisting of the saccule, utricle 
and semicircular canals, maintains a sense of position and balance.  Both the cochlea and the 
vestibular labyrinth are surrounded with perilymph and filled with endolymph.  The vibrations 
transmitted from the middle ear induce waves in the cochlear endolymph, which are interpreted 
as sound.  Hair cells with nerve endings in the cochlea respond to sounds of different frequencies 
convert them into impulses and transmit them to the brainstem via auditory nerves. 
 
Figure 1-1: Structure of the ear. 
Overview of the ear, with the outer ear, middle ear and the inner ear.  Figure is reproduced from 
Chittka et al. 2005 using the creative commons license [1]. 
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The development of the murine inner ear starts at E9.5 with the formation of an otic 
vesicle (Figure 1-2).  At E10.5, from the otocyst arise two protrusions: one forms the 
endolymphatic sac and the other coils to form the cochlea, leaving the center of the otocyst to 
reorganize into the vestibular labyrinth.  The lumen of the cochlea opens at E14.5. At this time, 
cochlear enlargement begins in Slc26a4
Δ/Δ 
mice [2, 3].  Normal luminal formation is regulated by 
balanced fluid secretion and absorption, which likely occur in the vestibular labyrinth and the 
endolymphatic sac, respectively [4].   
 
 
Figure 1-2: Embryonic murine inner ear development. 
ES: endolymphatic sac; ED: endolymphatic duct.  The inner ear develops from the auditory 
placode, which invaginates and forms the otic vesicle.  Figure is reproduced with permission 
from the author and the copyright holder, Karger, from Wangemann 2011 [2]. 
 
Enlargement of the vestibular aqueduct (EVA) is an inner ear malformation that is 
associated with syndromic and non-syndromic hearing loss in children [5].  SLC26A4 encodes a 




 exchanger expressed in the 
apical membrane of epithelial cells in the inner ear, kidney and thyroid [6-15].  Mutations in 
SLC26A4 that compromise or reduce pendrin expression or function are among the most 
common causes for sensorineural hearing loss associated with EVA.  Pendred syndrome, an 
autosomal recessive disease caused by SLC26A4 mutations, includes thyroid goiter and 
sensorineural hearing loss, which is also present in many cases of nonsyndromic EVA [16].  
Mutations of SLC26A4 have been observed in as many as 13.7% of deaf cases in some 
populations [17].   
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The human gene SLC26A4 and its murine ortholog Slc26a4 have substantial structural 





were developed to analyze the role of pendrin in the physiology of 
hearing and balance.  In Slc26a4
Δ/Δ 
mice, exon 8 is replaced with a neomycin cassette, which 
results in a frameshift.  No functional pendrin is produced.  Slc26a4
Δ/Δ 
mice develop an enlarged 
membranous labyrinth (Figure 1-3) in the inner ear and fail to acquire normal hearing and 
balance [16, 19].   
 
Figure 1-3: Cochlear enlargement in Slc26a4
Δ/Δ 
mice. 





.  (A) Cross-section of E18.5 Slc26a4
Δ/+
 otocyst.  (B) Cross-section 
of E18.5 Slc26a4
Δ/Δ 





otocysts.  Figure is reproduced with permission from the author and 
the copyright holder, Elsevier, from Griffith & Wangemann 2011 [5]. 
 
In the inner ear, pendrin is expressed in the epithelial cells of outer sulcus, spiral 
prominence and spindle cells of stria vascularis in the cochlea, transitional cells in the ampullae, 
utricle and saccule and mitochondria-rich cells in the endolymphatic sac [2] (Figure 1-4).  
Pendrin first expresses in the endolymphatic sac in the murine inner ear at E11.5, followed by the 
cochlea (E14.5) and the vestibular labyrinth (E16.5), which includes the utricle, saccule and 
semicircular canals.  There is a dramatic surge in pendrin expression in the endolymphatic sac 
between E13.5 and E14.5.  The expression of pendrin in the cochlea starts from the hook region 




Figure 1-4: Pendrin expression in the inner ear. 
(A) Structure of the inner ear.  (B) Pendrin expression sites in the cochlea: epithelial cells of the 
spiral prominence (long arrows) and spindle cells of stria vascularis (arrowhead).  Pendrin 
expression sites in the saccule or utricle (C) and the ampullae (D): transitional cells (arrows).  
Pendrin expression sites in the endolymphatic sac (E): mitochondria-rich cells (arrows).  Figure 
is reproduced with permission from the author and the copyright holder, Karger, from 
Wangemann 2013 [20]. 
 
Currently, the mechanisms for the enlargement of the membranous inner ear in 
Slc26a4
Δ/Δ 
mice are not clear.  It has been shown that the cochlear endolymphatic K
+
 
concentration increases from 10 mM during embryonic stages (E14.5) to approximately 140 mM 
at adult stages [21].  Further evidence suggests that fluid secretion takes place in the vestibular 
labyrinth [4].  If K
+ 
secretion is the source of fluid secretion that results in formation of the 







mice during embryonic stages and further, it would be 
expected that endolymphatic K
+
 concentration rises earlier in the utricle than in the cochlea.  In 
order to address this hypothesis, it was necessary to measure the K
+
 concentrations in the utricle. 
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Chapter 2 - Materials and Methods 
 Ethics Statement 
All animal experiments and procedures were approved by the Institutional Animal Care 
and Use Committee at Kansas State University (IACUC#: 3245.3). 
 
 Animals 




mice, free of known and suspected murine 
pathogens, was maintained at Kansas State University College of Veterinary Medicine.  
Slc26a4
Δ/+
 dams and Slc26a4
Δ/Δ 





offspring occurring at a near-Mendelian ratio (50.1 to 49.9).  The 
average gestational period was 21.4 (±0.6, n=29) days.  Gestational age was counted from the 
day when a vaginal plug was detected.  This day was set to embryonic (E) day 0.5 (E0.5).  
Pregnancies were tested by ultrasound (Terason t3000, Universal Medical Systems, Bedford 
Hills, NY).  In addition, gestational age was verified by evaluating gross morphological features 





mice ranging from E14.5 to P64 were used in the present study.  Time-pregnant dams 
were deeply anesthetized with 4% tri-bromo-ethanol and sacrificed by decapitation after 
harvesting embryos by sterile laparotomy.  Embryos were sacrificed by decapitation.  Neonatal 
mice (P0-P2) were anesthetized by a combination of intraperitoneal (i.p.) injection of 0.013 mL/g 
body weight of 4% tri-bromo-ethanol and rapid cooling on a slush of ice.  Older mice (>P3) were 
anesthetized solely by i.p. injection of 0.020 mL/g body weight of 4% tri-bromo-ethanol.  
Neonatal and older mice were sacrificed by decapitation after being deeply anesthetized. 
 
 Organ culture 
Procedures for organ culture were adapted with modifications from methods developed 




embryos were harvested at E15.5.  The 
cranium was cut medially in halves and intact otocysts were isolated from the temporal bone in 
sterile NaCl solution maintained at 4 
o
C.  The NaCl solution for dissection contained (in mM) 
6 
150 NaCl, 1.6 K2HPO4, 0.4 KH2PO4, 1 MgCl2, 0.7 CaCl2, 5 glucose, pH 7.4.  Preparations of the 





mice and submersed in DMEM medium (Cat#12800-017, Invitrogen, 
Carlsbad, CA) supplemented with 2.3 g/L NaHCO3, 10% fetal bovine serum (Cat# 10082, 
Invitrogen, Carlsbad, CA), and 1% penicillin-streptomycin (Cat# P7539, Sigma) (Figure 2-1). 
Tissues were incubated at 37°C in a humidified atmosphere enriched with 5% CO2. 
Preparations of utricles with attached ampullae of the anterior and lateral semicircular canals 




mice. Tissues were maintained in organ culture and periodically imaged by laser-scanning 
microscopy.  Endolymph was stained by injection of dye (BCECF acid + 5 mg/mL Fast Green) 
into the cochlea. Endolymphatic sacs were freed by microdissection and cut off from the inner 
ear with scissors.  The cutting force from the scissors sealed the epithelia at the cutting edge.  
Preparations were maintained in organ culture and compartment volumes were periodically 
monitored by confocal microscopy. 
 
 
Figure 2-1: Organ culture of inner ear tissues. 
A) Structure of the inner ear inside the cartilage.  B) Utricles (U) with two ampullae (A) attached 
were isolated and cultured in medium in glass-bottom dishes.  C) Isolated endolymphatic sacs 
(ES) were isolated and cultured in medium in glass-bottom dishes.  Figure drawn by Dr. Philine 
Wangemann and used with permission. 
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 Measurement of voltage and K+ concentrations 
K
+
 concentrations of the utricular endolymph and transepithelial voltages were measured 
with double-barreled ion-selective electrodes in vitro using established methods [21, 23] (Figure 
2-2).  Temporal bones were isolated from pre- and postnatal mice and placed in a bath chamber 
superfused at 37°C with HCO3
-
-containing physiological solutions (In-line heater SHM-8 and 
controller TC-344B, Warner instruments, Hamden, CT).  The physiological solution contained 
(in mM): 135 NaCl, 25 NaHCO3, 4 KCl, 1.5 CaCl2, 1 MgCl2 and 5 glucose and was bubbled 
with a humidified gas mixture consisting of 5% CO2 and 20% O2 to set the pH to pH 7.3 - pH 
7.4.  The bath chamber was grounded via a Ag/AgCl electrode that was bathed in a vial filled 
with 1 M KCl solution and connected to the bath chamber via an agar-bridge made from 150 
mM NaCl solution with 2% agar.  The endolymphatic K
+
 concentrations and the transepithelial 
voltages were measured with double-barreled K
+
-selective electrodes within 1 hour after 
sacrifice.  The double-barreled electrode approached the utricle via the oval window.  One barrel 
of the double-barreled electrode was used to measure the K
+
 concentration and the other barrel 
was used to measure the transepithelial voltage. 
 
Figure 2-2: Configuration for endolymphatic K
+
 measurements. 
Measurements of voltage and K
+
 concentrations in cochlear and utricular.  The voltage barrel of 
the electrode was used to measure the transepithelial voltage (V) and the ion barrel, with the tip 
filled with ion exchanger, was used to record the signal which was the sum of the ion-related 
voltage and the transepithelial voltage (VK++V).   Temporal bones were dissected and placed in a 
chamber superfused with warm artificial perilymph.  The stapes covering the oval window was 
removed to expose the utricle.  Both figures were drawn by Dr. Philine Wangemann and are used 
with permission.  Part A is reproduced with permission from the author and copyright holder, Dr. 
Philine Wangemann, from Li et al 2013 [21].   
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Electrodes were calibrated at 37°C immediately after measurement in the utricle using 
solutions containing 3, 10, 50 and 150 mM KCl with the sum of NaCl and KCl being constant at 
150 mM.  Data were recorded analog via a flat-bed chart recorder (BD12E, Kipp & Zonen, Delft, 
The Netherlands) for easy annotation.  Parallel, data were recorded digitally (Digidata 1322A 
and AxoScope 9, Molecular Devices, San Francisco, CA) for convenient analysis. 
 Confocal immunohistochemistry 
Otocysts were isolated from embryonic Slc26a4
Δ/+
 mice and fixed overnight at 4°C in 
Phosphate Buffered Saline (PBS contained (mM): 137 NaCl, 2.7 KCl, 10.1 Na2HPO4, and 1.8 
KH2PO4, pH 7.4) with 4% paraformaldehyde (Cat# 15714, Electron Microscopy Sciences, 
Hatfield, PA).  Fixed otocysts were processed through a sucrose gradient (10% and 20%, each 30 
min, followed by 30% overnight, all solutions in PBS at 4 °C), infiltrated with polyethylene 
glycol (Cat# 72592-B, Electron Microscopy Sciences) and cryosectioned (12 μm, CM3050S, 
Leica, Wetzlar, Germany).  Sections of the otocyst were mounted on charged slides (Cat# 22-
230-900, Fisher, Pittsburgh, PA) and blocked for 1 hour with 5% bovine serum albumin (BSA) 
in PBS containing 0.2% TritonX-100 (PBS-TX solution).  Sections were incubated at 4°C 
overnight with primary antibodies containing goat anti-KCNQ1 (1:200, Cat# SC-10646, Santa 
Cruz, Dallas, TX) or rabbit anti-SLC12A2 (1:200, Cat# AB3560P, Chemicon, Temecula, CA) 
and 2.5% BSA in PBS solution. Sections were washed 3 times for 2 min each with PBS-TX 
solution and incubated at room temperature for 1 hour with secondary antibodies containing 
Alexa Fluor 594 chicken-anti-goat (1:1000, Cat# A21468, Invitrogen, Grand Island, NY) or 
Alexa Fluor 594 goat-anti-rabbit (1:1000, Cat# A11037, Invitrogen) phalloidin 488 (1:40, Cat# 
A-12379, Invitrogen), DAPI (1:1000; Cat# D-3571, Invitrogen) and 2.5% BSA in PBS solution. 
After labeling, sections were washed another 3 times in PBS-TX solution with 2 min each, 
immersed with mounting medium (Cat# H-1400, Vector laboratories, Burlingame, CA), covered 
with a cover slip and examined by confocal laser scanning microscopy (LSM 510 Meta, Carl 
Zeiss, Göttingen, Germany). 
 Statistical analysis and presentation 
Data were presented as average ± SD with n being the number of replicates. Statistical 




Chapter 3 - Results 
 Vestibular labyrinth secretes fluid in vitro 
We first tested for fluid secretion by cultured embryonic vestibular labyrinth.  Embryonic 




mice at E15.5, which is near the 
onset of cochlear lumen formation.  Preparations of utricles with anterior and posterior ampullae 
attached were isolated by micro-dissection.  Tissues were maintained in organ culture and 
imaged periodically with confocal microscopy.  Freshly isolated tissues were imaged and 
recorded as 0 hours (hrs) after dissection.  For tissues from both genotypes, there was a healing 
process in the first few hours after microdissection.  Openings of the ampullae and utricle at the 
semicircular canals and the opening of the utricle at the saccular duct healed and closed 
automatically during organ culture.  The tissues shrank and got condensed during the healing 
process.  30 hours after dissection, there was an obvious swelling in the tissues of both 
genotypes.  All three compartments were blown up by fluids and the epithelia appeared 
stretched, thus making it easier for the laser to penetrate and therefore appearing lighter.   At ~50 
hours, tissues were substantially bigger, especially for the ones originally from E15.5 Slc26a4
Δ/Δ 
mice (Figure 3-1).   
The ion secretion rate in a cultured E15.5 Slc26a4
Δ/Δ 
utricle was estimated based on 
images taken at 9 hours and 52 hours after dissection.  At 9 hours the tissue was relatively flat 
and the volume was estimated based on three luminal areas, representing two ampullae and one 
utricle, and a common height (Figure 3-2).  The sum of the three luminal areas was 91,272 µm
2
.  
The average height of the lumen estimated to be 30 µm.  The volume of the lumen at 9 hours was 
estimated to be 2.7 nL, calculated from [2.7 nL=91,272×30 µm
3∙nL/106 µm3].  At 52 hours the 
tissue appeared swollen and the volume was estimated based on three spheres (Figure 3-2).  
Thereby their luminal volumes can be calculated with the equation: V = (4/3) π∙r3.  The volume 
of the swelled tissue at 52 hours was estimated to be 71.9 nL.  The major ions in the cytosol are 
KCl and NaCl, the total concentration of which stays constant at 150 mM.  With the increased 
luminal volume calculated from 9 hours to 52 hours, the ion secretion rate was 241.4 pmol/h, 
calculated from [241.4 pmol/h=(71.9-2.7) nL×150 mM/(52-9) hrs]. 
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Figure 3-1: Organ culture of the vestibular labyrinth. 




mice both sealed 
and formed cysts during ~50 hours (hrs) of organ culture.  At 0 hrs, freshly isolated tissues were 
transferred to glass-bottom dishes with medium and periodically imaged over ~50 hours. 
Relative compartments of the tissues were distinguishable during organ culture (blue arrows).  





mice are representatives of experiments yielding similar results.  The scale bar, 100 µm, pertains 
to all images. 
 
 
Figure 3-2: Estimations of the luminal volume of a cultured Slc26a4
Δ/Δ
 utricle. 
At 9 hrs, the luminal volume was estimated based on three areas, representing a utricle (U) and 
two attached ampullae (A) and a common height.  At 52 hrs when the tissue appeared swollen, 
the volume was estimated based on three spheres, representing a utricle (U) and two attached 
ampullae (A).  The areas circled by red lines are considered as lumen.  Same tissue as the E15.5 
Slc26a4
Δ/Δ 
utricle in Figure 3-1.  Scale bar, 50 µm, pertains to both images. 
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 Endolymphatic sacs absorb fluid in vitro 
Next, we determined if the embryonic endolymphatic sac spontaneously absorbs fluid 
when placed in culture.  Embryonic inner ears were harvested at E15.5 from Slc26a4
Δ/+ 
mice.  
The endolymphatic sacs were filled with 5 mg/mL fast green and carefully isolated from the 
inner ears without injury during dissection.  Preparations of endolymphatic sacs were cut off 
from the endolymphatic duct and were manually sealed by the cutting force of the scissors. 
Tissues were transferred to glass-bottom dishes and maintained in organ culture.  Injection of 
dye (fast green + BCECF acid) into the endolymphatic sacs helped visualize the tissue.  Image 
taking in time series started to count when the endolymphatic sac was freshly isolated from the 
inner ear.  At 0 hours (hrs), the sealed endolymphatic sac was nicely filled with dye and lay flat 
on bottom of culture dishes.  Shrinkage of the lumen and folding of the epithelium were 
observed within a few hours, which indicated there was fluid absorption (Figure 3-3).  The 
epithelium of the endolymphatic sac folded as the lumen got smaller.  There was almost no dye 
observed, implying there was no lumen inside the tissue. 
 
 
Figure 3-3: Organ culture of the endolymphatic sac. 
Preparations of endolymphatic sacs from E15.5 Slc26a4
Δ/+ 
mice shrank during 6 hours of culture 
(Experiments conducted by Dr. Philine Wangemann).  The recording of organ culture is 
representative of three similar experiments.  Scale bar, 50 µm, pertains to all images. 
 Endolymphatic K+ concentrations in the utricle rises after E16.5 
To determine if K
+
 secretion is the driving force for fluid secretion in the utricle, 
endolymphatic K
+
 concentrations and transepithelial voltages in the utricles prepared from pre- 
and postnatal mice were measured with double-barreled K
+
 selective electrodes.  Representative 
measurement traces were shown in Figure 3-4.  K
+
-selective electrodes were calibrated against 
standard K
+
 solutions with known concentrations.  K
+
 concentrations and voltages were fitted to 
the Nernst equation: 
12 
𝑉 = 𝑉𝑖 + 𝑆𝐾+ × 𝑙𝑜𝑔10([𝐾
+]) 





] represents the K
+
 concentrations.  K
+
 electrodes were found to be highly 
sensitive with SK+ near the theoretical value of 60 (52 ± 1 mV, n=72). 
 
Figure 3-4: Representative measurements with K
+
-selective electrodes. 
Recordings of measurement on K
+
 concentrations (top row) and transepithelial voltages (bottom 
row) in utricles isolated from Slc26a4
Δ/+
 mice at age E16.5, P2 and P63.  Traces with a purple 
background were recorded while the electrodes were in the lumen of utricle. 
 
At E16.5, endolymphatic K
+
 concentrations in the utricle were about ~10 mM in both 
genotypes and transepithelial voltage was about -10 mV in Slc26a4
Δ/+
 mice and about -2 mV in 
Slc26a4
Δ/Δ
 mice (Figure 3-5).  The K
+
 concentration rose to about 30 mM in Slc26a4
Δ/+
 mice at 
E17.5.  There appeared to be a delay of the rise in K
+
 concentration in Slc26a4
Δ/Δ
 mice during 
prenatal development.  In adult mice, the K
+
 concentration and the transepithelial voltage were 
150 mM and -22 mV in Slc26a4
Δ/+
 and 132 mM and -5 mV in Slc26a4
Δ/Δ





 concentrations and transepithelial voltages. 
Measurements of endolymphatic K
+
 concentrations and transepithelial voltages in isolated 
utricles.  Traces with a purple and green backgrounds indicated data collected from utricles 
isolated before and after birth, respectively.  17 out of the 72 reported measurements were 

















KCNQ1 and SLC12A2 expression in the utricle and ampullae is evident at 
E19.5 
We determined the expression of the K
+







cotransporter SLC12A2 in Slc26a4
Δ/+
 mice by immunohistochemistry.  Expression of KCNQ1 
was found in the apical membranes and SLC12A2 was found in the basolateral membranes of 




Immunohistochemistry of KCNQ1 (red, left image) and SLC12A2 (red, right image) in the 
vestibular labyrinth of E19.5 Slc26a4
Δ/+
 mice. F-actin was stained with phalloidin (green) and 
nuclei were stained with DAPI (blue).  (Data were collected by Xiangming Li).  VDC: vestibular 




Figure 3-6: Protein expression of KCNQ1 and SLC12A2 in the utricle. 
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Chapter 4 - Discussion 
The observations presented in this report are consistent with, and supportive of, previous 
assumptions and hypotheses that state that enlargement of the membranous labyrinth and failure 
to acquire normal hearing in Slc26a4
Δ/Δ
 mice result from of imbalanced fluid secretion and 
absorption [4].  The finding of a recent study, that involved the truncation of the vestibular 
labyrinth and the endolymphatic sac, implicated that these compartments participated in fluid 
secretion and absorption respectively [4].  If true, it would be expected that isolated sealed 
segments of the embryonic vestibular labyrinth would swell and that sealed embryonic 
endolymphatic sacs would shrink.  Our organ culture experiments addressed this hypothesis.  




 mice sealed and swelled during organ 
culture and ion secretion rates during the swelling process of utricles from Slc26a4
Δ/Δ
 mice can 
be estimated.  However, the mechanism of fluid secretion is yet to be figured out. 
 It is known that the K
+
 concentration increases significantly in cochlear endolymph 
during pre- and postnatal stages [21], lumen formation, however, precedes the rise in the K
+
 
concentration, which indicates the lumen formation is driven by K
+
 secretion.  The mechanisms 
for lumen formation during embryonic development are not clear, although the molecular 
mechanisms of K
+
 secretion into cochlear endolymph by strial marginal cells [24] and 
mechanisms of K
+
 secretion into the vestibular labyrinth by vestibular dark cells are well 
understood [25, 26].  Vestibular dark cells take up K
+











-cotransporter SLC12A2 [27, 28] and secrete K
+
 into 
endolymph across the apical membrane via the K
+
 channel KCNQ1/KCNE1 (previously known 
as KvLQT1and IsK or MinK).  The presence of KCNQ1 and SLC12A2 expression in the utricle 
and ampullae at E19.5 correlates with the elevated K+ concentration in utricular endolymph at 
this stage of development.  The rise of the K
+










-ATPase has been observed [29], however, expression and function of a 
putative non-selective cation channel needs to be determined. 
The negative voltages recorded in utricles isolated from adult mice suggest that tissues 
were deprived of oxygen during measurement.  However, this does not invalidate measurements 
16 
of the endolymphatic K
+
 concentrations since endolymphatic K
+
 concentrations are maintained 
for at least 50 min under anoxic conditions [30].  There was a more negative transepithelial 
voltage in the utricle of Slc26a4
Δ/+ 
mice at E16.5, which may be related to a non-selective cation 
channels, such as P2X2 or ENaC.  The growth phase of the inner ear, which includes the 
development of non-selective cation channels, comes to a conclusion at about E18.5 [20].  This 




 mice in 





 mice at E17.5 may at least in part originate with open transduction channels and other 
non-selective cation channels in hair cells and other epithelia cells [31, 32].  The smaller 
transepithelial voltage in adult utricles of Slc26a4
Δ/Δ
 mice is consistent with non-functional hair 
cells and with non-functional cation absorptive mechanisms in Slc26a4
Δ/Δ
 mice.   
The rise in the endolymphatic K
+





 mice occurred with a time course similar to changes in cochlear endolymphatic K
+
 
concentrations [21], although the cochlea disconnects from the vestibular labyrinth after E16.5 
[33].  There is no difference in endolymphatic K
+
 concentration between the cochlea and the 
utricle, which indicates K
+
 secretion is not the major driving force for cochlear lumen formation.  
According to the measurement on the cross-sectional area of scala media, the area in Slc26a4
Δ/Δ
 
mice after E16.5 is approximately 6-fold larger than that in Slc26a4
Δ/+
 mice [5] (Figure 1-3), 
which is most likely the reason for the delay of the rise of the K
+
 concentration in utricular and 
cochlear endolymph of Slc26a4
Δ/Δ
 mice.   
The observed shrinkage of the lumen and folding of the epithelium during organ culture 
of endolymphatic sacs isolated from E15.5 Slc26a4
Δ/+
 mice is consistent with fluid absorption in 
the endolymphatic sac [4].  Although difficulty in endolymphatic sac volume measurement 
hampered further investigation, the shrinkage of the tissues was obvious in 2-D recorded images 





 mice, a superior method for volume measurement must be established. 
In summary, this study has determined the respective roles of the epithelia of embryonic 
utricles and endolymphatic sacs in fluid secretion and absorption.  The present result supports the 
concept that a balance between fluid secretion and absorption is necessary for cochlear 
development (Figure 4-1).  We also measured the endolymphatic K
+
 concentrations in the utricle 




 mice and found that K
+
 concentrations increased 
17 
after E16.5.  Expression of the K
+







likely mediate the rise in K
+
 concentration observed at E19.5.  The observed delay of the rise of 
the K
+
 concentration in utricular and cochlear endolymph of Slc26a4
Δ/Δ
 mice likely results from 
the enlarged endolymph volume. 
 
 
Figure 4-1: Source of fluid secretion and absorption in the inner ear. 
The image on the left shows the inner ear structure and sources of fluid secretion and absorption.  
The isolated sealed utricles and endolymphatic sacs swelled and shrank respectively, consistent 
with fluid secretion and absorption.  The swelling of the Slc26a4
Δ/Δ
 mice inner ear starts at E14.5 
[2], which is earlier than the rise in endolymphatic K
+
 concentration in the utricle and cochlea, 
indicating the K
+
 secretion is not the major driving force for fluid secretion.  The mechanism of 
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must also be sought from that source.  If such permission is not obtained then that material
may not be included in your publication/copies. Suitable acknowledgement to the source
must be made, either as a footnote or in a reference list at the end of your publication, as
follows:
"Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of
chapter, Pages No., Copyright (Year), with permission from Elsevier [OR APPLICABLE
SOCIETY COPYRIGHT OWNER]." Also Lancet special credit ­ "Reprinted from The
Lancet, Vol. number, Author(s), Title of article, Pages No., Copyright (Year), with
permission from Elsevier."
4. Reproduction of this material is confined to the purpose and/or media for which
permission is hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be
altered/adapted minimally to serve your work. Any other abbreviations, additions, deletions
and/or any other alterations shall be made only with prior written authorization of Elsevier
Ltd. (Please contact Elsevier at permissions@elsevier.com)
6. If the permission fee for the requested use of our material is waived in this instance,
please be advised that your future requests for Elsevier materials may attract a fee.
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7. Reservation of Rights: Publisher reserves all rights not specifically granted in the
combination of (i) the license details provided by you and accepted in the course of this
licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment
terms and conditions.
8. License Contingent Upon Payment: While you may exercise the rights licensed
immediately upon issuance of the license at the end of the licensing process for the
transaction, provided that you have disclosed complete and accurate details of your proposed
use, no license is finally effective unless and until full payment is received from you (either
by publisher or by CCC) as provided in CCC's Billing and Payment terms and conditions.  If
full payment is not received on a timely basis, then any license preliminarily granted shall be
deemed automatically revoked and shall be void as if never granted.  Further, in the event
that you breach any of these terms and conditions or any of CCC's Billing and Payment
terms and conditions, the license is automatically revoked and shall be void as if never
granted.  Use of materials as described in a revoked license, as well as any use of the
materials beyond the scope of an unrevoked license, may constitute copyright infringement
and publisher reserves the right to take any and all action to protect its copyright in the
materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed
material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and
their respective officers, directors, employees and agents, from and against any and all
claims arising out of your use of the licensed material other than as specifically authorized
pursuant to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed,
assigned, or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing
signed by both parties (or, in the case of publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any
purchase order, acknowledgment, check endorsement or other writing prepared by you,
which terms are inconsistent with these terms and conditions or CCC's Billing and Payment
terms and conditions.  These terms and conditions, together with CCC's Billing and Payment
terms and conditions (which are incorporated herein), comprise the entire agreement
between you and publisher (and CCC) concerning this licensing transaction.  In the event of
any conflict between your obligations established by these terms and conditions and those
established by CCC's Billing and Payment terms and conditions, these terms and conditions
shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described
in this License at their sole discretion, for any reason or no reason, with a full refund payable
to you.  Notice of such denial will be made using the contact information provided by you. 
Failure to receive such notice will not alter or invalidate the denial.  In no event will Elsevier
or Copyright Clearance Center be responsible or liable for any costs, expenses or damage
incurred by you as a result of a denial of your permission request, other than a refund of the
amount(s) paid by you to Elsevier and/or Copyright Clearance Center for denied
permissions.
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LIMITED LICENSE
The following terms and conditions apply only to specific license types:
15. Translation: This permission is granted for non­exclusive world English rights only
unless your license was granted for translation rights. If you licensed translation rights you
may only translate this content into the languages you requested. A professional translator
must perform all translations and reproduce the content word for word preserving the
integrity of the article. If this license is to re­use 1 or 2 figures then permission is granted for
non­exclusive world rights in all languages.
16. Posting licensed content on any Website: The following terms and conditions apply as
follows: Licensing material from an Elsevier journal: All content posted to the web site must
maintain the copyright information line on the bottom of each image; A hyper­text must be
included to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier homepage for books at
http://www.elsevier.com; Central Storage: This license does not include permission for a
scanned version of the material to be stored in a central repository such as that provided by
Heron/XanEdu.
Licensing material from an Elsevier book: A hyper­text link must be included to the Elsevier
homepage at http://www.elsevier.com . All content posted to the web site must maintain the
copyright information line on the bottom of each image.
Posting licensed content on Electronic reserve: In addition to the above the following
clauses are applicable: The web site must be password­protected and made available only to
bona fide students registered on a relevant course. This permission is granted for 1 year only.
You may obtain a new license for future website posting.
17. For journal authors: the following clauses are applicable in addition to the above:
Preprints:
A preprint is an author's own write­up of research results and analysis, it has not been peer­
reviewed, nor has it had any other value added to it by a publisher (such as formatting,
copyright, technical enhancement etc.).
Authors can share their preprints anywhere at any time. Preprints should not be added to or
enhanced in any way in order to appear more like, or to substitute for, the final versions of
articles however authors can update their preprints on arXiv or RePEc with their Accepted
Author Manuscript (see below).
If accepted for publication, we encourage authors to link from the preprint to their formal
publication via its DOI. Millions of researchers have access to the formal publications on
ScienceDirect, and so links will help users to find, access, cite and use the best available
version. Please note that Cell Press, The Lancet and some society­owned have different
preprint policies. Information on these policies is available on the journal homepage.
Accepted Author Manuscripts: An accepted author manuscript is the manuscript of an
article that has been accepted for publication and which typically includes author­
incorporated changes suggested during submission, peer review and editor­author
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communications.
Authors can share their accepted author manuscript:
         immediately
via their non­commercial person homepage or blog
by updating a preprint in arXiv or RePEc with the accepted manuscript
via their research institute or institutional repository for internal institutional
uses or as part of an invitation­only research collaboration work­group
directly by providing copies to their students or to research collaborators for
their personal use
for private scholarly sharing as part of an invitation­only work group on
commercial sites with which Elsevier has an agreement
         after the embargo period
via non­commercial hosting platforms such as their institutional repository
via commercial sites with which Elsevier has an agreement
In all cases accepted manuscripts should:
         link to the formal publication via its DOI
         bear a CC­BY­NC­ND license ­ this is easy to do
         if aggregated with other manuscripts, for example in a repository or other site, be
shared in alignment with our hosting policy not be added to or enhanced in any way to
appear more like, or to substitute for, the published journal article.
Published journal article (JPA): A published journal article (PJA) is the definitive final
record of published research that appears or will appear in the journal and embodies all
value­adding publishing activities including peer review co­ordination, copy­editing,
formatting, (if relevant) pagination and online enrichment.
Policies for sharing publishing journal articles differ for subscription and gold open access
articles:
Subscription Articles: If you are an author, please share a link to your article rather than the
full­text. Millions of researchers have access to the formal publications on ScienceDirect,
and so links will help your users to find, access, cite, and use the best available version.
Theses and dissertations which contain embedded PJAs as part of the formal submission can
be posted publicly by the awarding institution with DOI links back to the formal
publications on ScienceDirect.
If you are affiliated with a library that subscribes to ScienceDirect you have additional
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private sharing rights for others' research accessed under that agreement. This includes use
for classroom teaching and internal training at the institution (including use in course packs
and courseware programs), and inclusion of the article for grant funding purposes.
Gold Open Access Articles: May be shared according to the author­selected end­user
license and should contain a CrossMark logo, the end user license, and a DOI link to the
formal publication on ScienceDirect.
Please refer to Elsevier's posting policy for further information.
18. For book authors the following clauses are applicable in addition to the above:  
Authors are permitted to place a brief summary of their work online only. You are not
allowed to download and post the published electronic version of your chapter, nor may you
scan the printed edition to create an electronic version. Posting to a repository: Authors are
permitted to post a summary of their chapter only in their institution's repository.
19. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be
submitted to your institution in either print or electronic form. Should your thesis be
published commercially, please reapply for permission. These requirements include
permission for the Library and Archives of Canada to supply single copies, on demand, of
the complete thesis and include permission for Proquest/UMI to supply single copies, on
demand, of the complete thesis. Should your thesis be published commercially, please
reapply for permission. Theses and dissertations which contain embedded PJAs as part of
the formal submission can be posted publicly by the awarding institution with DOI links
back to the formal publications on ScienceDirect.
 
Elsevier Open Access Terms and Conditions
You can publish open access with Elsevier in hundreds of open access journals or in nearly
2000 established subscription journals that support open access publishing. Permitted third
party re­use of these open access articles is defined by the author's choice of Creative
Commons user license. See our open access license policy for more information.
Terms & Conditions applicable to all Open Access articles published with Elsevier:
Any reuse of the article must not represent the author as endorsing the adaptation of the
article nor should the article be modified in such a way as to damage the author's honour or
reputation. If any changes have been made, such changes must be clearly indicated.
The author(s) must be appropriately credited and we ask that you include the end user
license and a DOI link to the formal publication on ScienceDirect.
If any part of the material to be used (for example, figures) has appeared in our publication
with credit or acknowledgement to another source it is the responsibility of the user to
ensure their reuse complies with the terms and conditions determined by the rights holder.
Additional Terms & Conditions applicable to each Creative Commons user license:
CC BY: The CC­BY license allows users to copy, to create extracts, abstracts and new
works from the Article, to alter and revise the Article and to make commercial use of the
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Article (including reuse and/or resale of the Article by commercial entities), provided the
user gives appropriate credit (with a link to the formal publication through the relevant
DOI), provides a link to the license, indicates if changes were made and the licensor is not
represented as endorsing the use made of the work. The full details of the license are
available at http://creativecommons.org/licenses/by/4.0.
CC BY NC SA: The CC BY­NC­SA license allows users to copy, to create extracts,
abstracts and new works from the Article, to alter and revise the Article, provided this is not
done for commercial purposes, and that the user gives appropriate credit (with a link to the
formal publication through the relevant DOI), provides a link to the license, indicates if
changes were made and the licensor is not represented as endorsing the use made of the
work. Further, any new works must be made available on the same conditions. The full
details of the license are available at http://creativecommons.org/licenses/by­nc­sa/4.0.
CC BY NC ND: The CC BY­NC­ND license allows users to copy and distribute the Article,
provided this is not done for commercial purposes and further does not permit distribution of
the Article if it is changed or edited in any way, and provided the user gives appropriate
credit (with a link to the formal publication through the relevant DOI), provides a link to the
license, and that the licensor is not represented as endorsing the use made of the work. The
full details of the license are available at http://creativecommons.org/licenses/by­nc­nd/4.0.
Any commercial reuse of Open Access articles published with a CC BY NC SA or CC BY
NC ND license requires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
         Associating advertising with the full text of the Article
         Charging fees for document delivery or access
         Article aggregation
         Systematic distribution via e­mail lists or share buttons
Posting or linking by commercial companies for use by customers of those companies.
 
20. Other Conditions:
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Questions? customercare@copyright.com or +1­855­239­3415 (toll free in the US) or
+1­978­646­2777.


